Search Results - "Akeroyd, Julia M."

Gender Disparities in Evidence-Based Statin Therapy in Patients With Cardiovascular Disease by Virani, Salim S., MD, PhD, Woodard, LeChauncy D., MD, MPH, Ramsey, David J., PhD, Urech, Tracy H., MPH, Akeroyd, Julia M., MPH, Shah, Tina, MD, Deswal, Anita, MD, MPH, Bozkurt, Biykem, MD, PhD, Ballantyne, Christie M., MD, Petersen, Laura A., MD, MPH

“…Studies have shown gender disparities in cholesterol care in patients with cardiovascular disease (CVD), with women less likely than men to have low-density…”
Get full text

Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease by Virani, Salim S., Ramsey, David J., Westerman, Dax, Kuebeler, Mark K., Chen, Liang, Akeroyd, Julia M., Gobbel, Glenn T., Ballantyne, Christie M., Petersen, Laura A., Turchin, Alexander, Matheny, Michael E.

Get full text

Comparative Effectiveness of Outpatient Cardiovascular Disease and Diabetes Care Delivery between Advanced Practice Providers and Physician Providers in Primary Care: Implications for Care under the Affordable Care Act by Virani, Salim S., MD, PhD, Akeroyd, Julia M., MPH, Ramsey, David J., PhD, Chan, Winston J., MPH, Frazier, Lorraine, PhD, RN, Nasir, Khurram, MD, Rajan, Suja, PhD, MS, Ballantyne, Christie M., MD, Petersen, Laura A., MD, MPH

“…Abstract Objective To compare quality of diabetes and cardiovascular disease (CVD) care between advanced practice providers (APPs) and physicians in a primary…”
Get full text

Risk Factor Optimization And Guideline Directed Medical Therapy In US Veterans With Peripheral Arterial And Ischemic Cerebrovascular Disease Compared To Veterans With Coronary Heart Disease by Hira, Ravi S., MD, Cowart, Jennifer B., MD, Akeroyd, Julia M., MPH, Ramsey, David J., PhD, Pokharel, Yashashwi, MD, Nambi, Vijay, MD, PhD, Jneid, Hani, MD, Deswal, Anita, MD, MPH, Denktas, Ali, MD, Taylor, Addison, MD, Nasir, Khurram, MD, Ballantyne, Christie M., MD, Petersen, Laura A., MD, MPH, Virani, Salim S., MD, PhD

“…Abstract Cardiovascular disease (CVD) is a systemic process involving multiple vascular beds and includes coronary heart disease (CHD), ischemic…”
Get full text

Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin-Associated Side Effects by Ahmed, Sarah T, Akeroyd, Julia M, Mahtta, Dhruv, Street, Richard, Slagle, Jason, Navar, Ann Marie, Stone, Neil J, Ballantyne, Christie M, Petersen, Laura A, Virani, Salim S

“…Background Despite guideline recommendations and clinical trial data suggesting benefit, statin therapy use in patients with atherosclerotic cardiovascular…”
Get full text

Provider understanding of the 2013 ACC/AHA cholesterol guideline by Virani, Salim S., MD, PhD, Pokharel, Yashashwi, MD, Steinberg, Lynne, PhD, Chan, Winston, MPH, Akeroyd, Julia M., MPH, Gowani, Saqib Ali, MD, Kalra, Ankur, MD, Polsani, Venkateshwar, MD, Miedema, Michael D., MD, MPH, Jones, Peter H., MD, Nambi, Vijay, MD, PhD, Petersen, Laura A., MD, MPH, Ballantyne, Christie M., MD

“…Background Providers' understanding of the 2013 American College of Cardiology (ACC)/American Heart Association (AHA) cholesterol guideline in clinical…”
Get full text

Leveraging structured and unstructured electronic health record data to detect reasons for suboptimal statin therapy use in patients with atherosclerotic cardiovascular disease by Gobbel, Glenn T., Matheny, Michael E., Reeves, Ruth R., Akeroyd, Julia M., Turchin, Alexander, Ballantyne, Christie M., Petersen, Laura A., Virani, Salim S.

“…To determine whether natural language processing (NLP) of unstructured medical text can improve identification of ASCVD patients not using high-intensity…”
Get full text

Adherence to cardiovascular medications in the South Asian population:A systematic review of current evidence and future directions by Akeroyd, Julia M, Chan, Winston J, Kamal, Ayeesha K, Palaniappan, Latha, Virani, Salim S

“…AIM: To review methods of assessing adherence and strategies to improve adherence to cardiovascular disease(CVD) medications,among South Asian CVD patients…”
Get full text

Implications for Ezetimibe Therapy Use Based on IMPROVE-IT Criteria by Virani, Salim S., MD, PhD, Akeroyd, Julia M., MPH, Nambi, Vijay, MD, PhD, Maddox, Thomas M., MD, MSc, Gillette, Michael A., PharmD, Michael Ho, P., MD, PhD, Rumsfeld, John, MD, PhD, Petersen, Laura A., MD, MPH, Ballantyne, Christie M., MD

“…Abstract Purpose In the IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT), simvastatin/ezetimibe combination was associated…”
Get full text

Provider Type and Quality of Outpatient Cardiovascular Disease Care by Virani, Salim S., MD, PhD, Maddox, Thomas M., MD, MSc, Chan, Paul S., MD, MSc, Tang, Fengming, MS, Akeroyd, Julia M., MPH, Risch, Samantha A., BS, Oetgen, William J., MD, MBA, Deswal, Anita, MD, MPH, Bozkurt, Biykem, MD, PhD, Ballantyne, Christie M., MD, Petersen, Laura A., MD, MPH

“…Abstract Background The current number of physicians will not be sufficient to accommodate 30 to 40 million Americans expected to secure health coverage with…”
Get full text

Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs by Mahtta, Dhruv, Ramsey, David J, Lee, Michelle T, Chen, Liang, Al Rifai, Mahmoud, Akeroyd, Julia M, Vaughan, Elizabeth M, Matheny, Michael E, Santo, Karla Rodrigues do Espirito, Navaneethan, Sankar D, Lavie, Carl J, Birnbaum, Yochai, Ballantyne, Christie M, Petersen, Laura A, Virani, Salim S

“…There is mounting evidence regarding the cardiovascular benefits of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor…”
Get full text

Composite Restorations May Lead to Increased Concentrations of Salivary and Urinary BPA by Akeroyd, Julia M., MPH, Maserejian, Nancy N., ScD

“…Article Title and Bibliographic Information Bisphenol A and other compounds in human saliva and urine associated with the placement of composite restorations…”
Get full text

A dataset to assess providers׳ knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline by Pokharel, Yashashwi, Steinberg, Lynne, Chan, Winston, Akeroyd, Julia M., Jones, Peter H., Nambi, Vijay, Nasir, Khurram, Petersen, Laura, Ballantyne, Christie M., Virani, Salim S.

“…We previously examined provider׳s understanding of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) cholesterol management…”
Get full text

Predictors, Disparities, and Facility-Level Variation: SGLT2 Inhibitor Prescription Among US Veterans With CKD by Gregg, L. Parker, Ramsey, David J., Akeroyd, Julia M., Jafry, Shehrezade A., Matheny, Michael E., Virani, Salim S., Navaneethan, Sankar D.

“…Sodium/glucose cotransporter 2 (SGLT2) inhibitors are recommended for type 2 diabetes mellitus (T2DM) in patients with chronic kidney disease (CKD) or…”
Get full text

Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk): Insights From the Department of Veterans Affairs by Virani, Salim S, Akeroyd, Julia M, Nambi, Vijay, Heidenreich, Paul A, Morris, Pamela B, Nasir, Khurram, Michos, Erin D, Bittner, Vera A, Petersen, Laura A, Ballantyne, Christie M

Get full text

Premature Coronary Heart Disease in South Asians: Burden and Determinants by Ahmed, Sarah T., Rehman, Hasan, Akeroyd, Julia M., Alam, Mahboob, Shah, Tina, Kalra, Ankur, Virani, Salim S.

“…Purpose of Review While the burden of cardiovascular disease (CVD) is on the decline globally, it is on the rise among South Asians. South Asians are also…”
Get full text

Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial: Insight From the Veterans Affairs Healthcare System by Jia, Xiaoming, Akeroyd, Julia M, Nasir, Khurram, Nambi, Vijay, Ballantyne, Christie M, Petersen, Laura A, Virani, Salim S

Get full text

Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry by Virani, Salim S, Maddox, Thomas M, Chan, Paul S, Tang, Fengming, Akeroyd, Julia M, Risch, Samantha A, Oetgen, William J, Deswal, Anita, Bozkurt, Biykem, Ballantyne, Christie M, Petersen, Laura A

“…The current number of physicians will not be sufficient to accommodate 30 to 40 million Americans expected to secure health coverage with Affordable Care Act…”
Get full text

Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018 AHA/ACC Cholesterol Guidelines by Virani, Salim S., Akeroyd, Julia M., Smith, Sidney C., Al-Mallah, Mouaz, Maddox, Thomas M., Morris, Pamela B., Petersen, Laura A., Ballantyne, Christie M., Grundy, Scott M., Stone, Neil J.

“…Sixty-seven percent of these very high risk patients had low-density lipoprotein cholesterol (LDL-C) of ≥70 mg/dl, and 72% had either LDL-C ≥70 mg/dl or…”
Get full text

Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health System by Jia, Xiaoming, Al Rifai, Mahmoud, Ramsey, David J., Ahmed, Sarah T., Akeroyd, Julia M., Nambi, Vijay, Ballantyne, Christie M., Petersen, Laura A., Stone, Neil J., Virani, Salim S.

“…Measurement with a lipid panel after statin initiation and in long-term follow-up is recommended in both 2013 and 2018 cholesterol guidelines to assess statin…”
Get full text